RBR-9ksh5f4尚未招募4 期
Phase IV study to evaluate the safety and immunogenicity of the Covid-19 adserbed (inactivated) vaccine of the Instituto Butantan in immunocompromised hosts
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo0 个研究点开始时间: 2021年5月26日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 59Y（—）
入选标准
- •Adults aged from 18 to 59 years, belonging to one of the following groups: Solid organs transplant recipients - kidney, liver, heart and lung; Chronic Kidney disease pre-transplantation; Liver cirrhosis pre-transplantation; Hematopoietic stem cell transplantation; Cancer in active therapy; Adults with innate immunity errors, diseases with predominant antibody deficiency; Immune-mediated rheumatic diseases; Immunocompetent persons (comparator group)
排除标准
- •Have previously received any Covid vaccine; History of allergy to any component of the vaccine; Have received any other vaccine up to 15 days before inclusion in the study; Acute illness or fever at the time of inclusion; Behavioral, cognitive or psychiatric illness that, in the opinion of the researchers, affects the ability to understand and collaborate with the requirements of the research protocol Alcohol or drug addiction; Any other condition that, according to the investigator's judgment, may prejudice the study procedures
研究者
相似试验
进行中（未招募）
1 期
A clincal study to evaluate the safety of a polio vaccine type 2 given orally in healthy children aged 1 to 5 years previously treated with inactivated polio vaccine in Lithuaniaevaluation of safety of SABIN mOPV2 in healthy IPV-vaccinated children of 1 – 5 years of age (Polio disease)MedDRA version: 18.0Level: LLTClassification code 10036016Term: Poliomyelitis NOSSystem Organ Class: 100000004862EUCTR2015-003544-39-LTFIDEC - Fighting Infectious Diseases in Emerging Countries
进行中（未招募）
1 期
A vaccine study in healthy adults to evaluate the safety and immune response of a licensed oral polio vaccine containing the polio vaccine 2 straiPolio diseaseMedDRA version: 18.0Level: HLTClassification code 10036017Term: Poliomyelitis viral infectionsSystem Organ Class: 100000004862EUCTR2015-003325-33-BEniversity of Antwerp100
进行中（未招募）
1 期
A vaccine study in healthy adults to evaluate the safety and immune response of a licensed oral polio vaccine containing 3 polio vaccine strains.Historic tOPV can result in the emergence of circulating vaccine-derived polioviruses (cVDPVs): the attenuated strains of poliovirus from the vaccine infect un-immunized individuals, replicate, circulate in the population, and may eventually mutate enough to become virulent and effect vaccine-associated paralytic poliomyelitis (VAPP).MedDRA version: 18.0Level: HLTClassification code 10036017Term: Poliomyelitis viral infectionsSystem Organ Class: 100000004862EUCTR2015-003324-32-BEniversity of Antwerp128
进行中（未招募）
1 期
Investigating a vaccine against plague in Uganda (PlaVac Uganda)Prevention of plague caused by the intracellular bacterium Yersinia pestisInfections and InfestationsISRCTN79243381niversity of Oxford36
进行中（未招募）
4 期
To compare combination of study with marketed other combination of drug in patients having both anxiety and depression.CTRI/2022/11/047050Mankind Pharma Limited